Year: 2024
Type: conference-paper
Study design: Observational Study
Abstract: Background Sarcopenia is defined by low levels of muscle strength, muscle quantity/quality, and, physical performance (1). Although sarcopenia in clinical cases is observed in Huntington’s disease (HD) the clinical diagnosis is still challenging. The Consensus 20191 recommends 2 tools for early identification of cases at risk: Strength, assistance walking, rise from a chair, climb stairs, and fall questionnaire (SARC-F) (2) and the Ishii Test (3). Aims To assess the concordance between SARC-F and SARC-CalF (4) vs. Ishii test in HD. Methods/Techniques Cross-sectional and observational study. SARC-F is a 5-item questionnaire that is self-reported by patients based on the self-perception. SARC-CalF uses the same scores as SARC-F plus calf circumference measurement. On the other hand, Ishii test included age, grip strength, and calf circumference, assessed by health personnel. To analyze concordance, we used the Cohen´s kappa coefficient (CK Coef.). Results/Outcome Thirty-seven self-ambulatory participants, 60% women, CAG 43 ± 2.76, age 53.4 ± 11.9 years, BMI 24.3 ± 2.9, 62% moderate-high adherence Mediterranean diet, UHDRS motor 29.8 ± 22.1 and TFC 9.6 ± 3.2. The CK coef. were SARC-F vs. Ishii test 0.36 (p<0.05), and SARC-CalF vs. Ishii test 0.55 (p<0.05). Conclusions In HD, compared to the Ichii test, SARC-F cannot identify early cases at risk for sarcopenia. However, SARC-CalF had higher concordance with the Ichii test compared to SARC-F. The identification of cases at risk of sarcopenia is important and needs early lifestyle interventions, including physical activity and Mediterranean diet. Further research is needed to confirm these findings and the benefits of early lifestyle interventions. References Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169. Erratum in: Age Ageing. 2019 Jul 1;48(4):601. PMID: 30312372; PMCID: PMC6322506. Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):28-36. doi: 10.1002/jcsm.12048. Epub 2015 Jul 7. PMID: 27066316; PMCID: PMC4799853. Ishii S, Tanaka T, Shibasaki K, Ouchi Y, Kikutani T, Higashiguchi T, Obuchi SP, Ishikawa-Takata K, Hirano H, Kawai H, Tsuji T, Iijima K. Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int. 2014 Feb;14 Suppl 1:93-101. doi: 10.1111/ggi.12197. PMID: 24450566. ( Barbosa-Silva TG, Menezes AM, Bielemann RM, Malmstrom TK, Gonzalez MC; Grupo de Estudos em Composição Corporal e Nutrição (COCONUT). Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice. J Am Med Dir Assoc. 2016 Dec 1;17(12):1136-1141. doi: 10.1016/j.jamda.2016.08.004. Epub 2016 Sep 17. PMID: 27650212.
Authors: Jéssica Rivadeneyra-Posadas, Esther Cubo-Delgado, Lucía Simón-Vicente, Fernando Vázquez-Sánchez, Laura Aguado-García, Gonzalo Gámez Leyva-Hernández, Miriam Saiz-Rodríguez, Natividad Mariscal-Pérez, M Teresa Almarza-Fernández, Cristina Gaudo-Naval, Ana W Heras-González, Dolores Díaz-Piñeiro, Ignacio Muñoz-Siscart, Irene Miguel-Pérez
Institutions: Hospital Universitario de Burgos, Universidad de Burgos
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4402374569